FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 331:95-106 July 14, 1994 Number 2 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

The retina, the transparent neural tissue lining the interior of the eye, is the initial receptor for visual stimuli. Exciting progress has been made in many areas of retinal investigation, from genetic breakthroughs in retinoblastoma and retinitis pigmentosa to sophistication in the medical and surgical therapy of retinal diseases. This article reviews recent clinical developments in diabetic retinopathy, retinal detachment, retinal manifestations of the acquired immunodeficiency syndrome (AIDS), and age-related macular degeneration.

Classically, the retina is separated into 10 layers on light microscopy (Figure 1)¹. The photoreceptors, consisting of rod and cone cells, are located near the . . . [Full Text of this Article]

Diabetic Retinopathy

Nonproliferative Diabetic Retinopathy

Proliferative Diabetic Retinopathy

Retinal Detachment

Retinal Detachment with Proliferative Vitreoretinopathy

Pneumatic Retinopexy

Retinal Manifestations of AIDS

Age-Related Macular Degeneration

Identification of Choroidal Neovascularization

Treatment

Source Information

From the Department of Ophthalmology, Harvard Medical School, and the Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Boston.

Address reprint requests to Dr. D'Amico at the Massachusetts Eye and Ear Infirmary, 243 Charles St., Boston, MA 02114.

References

This article has been cited by other articles:

• Bergman, P. B., Moravski, C. J., Edmondson, S. R., Russo, V. C., Bach, L. A., Wilkinson-Berka, J. L., Werther, G. A. (2005). Expression of the IGF System in Normal and Diabetic Transgenic (mRen-2)27 Rat Eye. IOVS 46: 2708-2715 [Abstract] [Full Text]  
• Husain, D., Kim, I., Gauthier, D., Lane, A. M., Tsilimbaris, M. K., Ezra, E., Connolly, E. J., Michaud, N., Gragoudas, E. S., O'Neill, C. A., Beyer, J. C., Miller, J. W. (2005). Safety and Efficacy of Intravitreal Injection of Ranibizumab in Combination With Verteporfin PDT on Experimental Choroidal Neovascularization in the Monkey. Arch Ophthalmol 123: 509-516 [Abstract] [Full Text]  
• Gaudreault, J., Fei, D., Rusit, J., Suboc, P., Shiu, V. (2005). Preclinical Pharmacokinetics of Ranibizumab (rhuFabV2) after a Single Intravitreal Administration. IOVS 46: 726-733 [Abstract] [Full Text]  
• Wood, D. L., Panda, D., Wiernicki, T. R., Wilson, L., Jordan, M. A., Singh, J. P. (1997). Inhibition of Mitosis and Microtubule Function through Direct Tubulin Binding by a Novel Antiproliferative Naphthopyran LY290181. Mol. Pharmacol. 52: 437-444 [Abstract] [Full Text]